Gene susceptibility to oxidative damage: From single nucleotide polymorphisms to function

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 731, Issue 1-2, 2012, Pages 1-13

  Simonelli, Valeria ^a   Mazzei, Filomena ^a   D'Errico, Mariarosaria ^a   Dogliotti, Eugenia ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

DNA repair; Genotype phenotype correlation; Oxidative DNA damage; Single nucleotide polymorphism

Indexed keywords

8 OXOGUANINE DNA GLYCOSYLASE; AP ENDONUCLEASE 1; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; DNA DIRECTED DNA POLYMERASE BETA; DNA GLYCOSYLASE MUTY; DNA GLYCOSYLTRANSFERASE; NEI LIKE PROTEIN 1; NEI LIKE PROTEIN 2; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; UNCLASSIFIED DRUG; XRCC1 PROTEIN;

8 OXOGUANINE DNA GLYCOSYLASE GENE; AP ENDONUCLEASE 1 GENE; DNA DAMAGE; DNA POLYMERASE BETA GENE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MUTATOR GENE; MUTYH GENE; NEI LIKE PROTEIN 1 GENE; NEI LIKE PROTEIN 2 GENE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; POLY ADP RIBOSE POLYMERASE 1 GENE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STRUCTURE ANALYSIS; X RAY CROSS COMPLEMENTING GROUP 1 GENE;

DNA DAMAGE; DNA REPAIR; DNA REPAIR ENZYMES; HUMANS; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; REACTIVE OXYGEN SPECIES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84856209804     PISSN: 00275107     EISSN: 09218262     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2011.10.012     Document Type: Review

References (171)

1. Cooke M.S., Evans M.D., Dizdaroglu M., Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J. 2003, 17:1195-1214.
2. Giustarini D., Dalle-Donne I., Tsikas D., Rossi R. Oxidative stress and human diseases: origin, link, measurement, mechanisms, and biomarkers. Crit. Rev. Clin. Lab. Sci. 2009, 46:241-281.
3. Fortini P., Pascucci B., Parlanti E., D'Errico M., Simonelli V., Dogliotti E. 8-Oxoguanine DNA damage: at the crossroad of alternative repair pathways. Mutat. Res. 2003, 531:127-139.
4. Bohr V.A., Stevnsner T., de N.C., Souza-Pinto Mitochondrial DNA repair of oxidative damage in mammalian cells. Gene 2002, 286:127-134.
5. Al-Tassan N., Chmiel N.H., Maynard J., Fleming N., Livingston A.L., Williams G.T., Hodges A.K., Davies D.R., David S.S., Sampson J.R., Cheadle J.P. Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors. Nat. Genet. 2002, 30:227-232.
6. Vartanian V., Lowell B., Minko I.G., Wood T.G., Ceci J.D., George S., Ballinger S.W., Corless C.L., McCullough A.K., Lloyd R.S. The metabolic syndrome resulting from a knockout of the NEIL1 DNA glycosylase. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:1864-1869.
7. Shields P.G., Harris C.C. Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J. Clin. Oncol. 2000, 18:2309-2315.
8. Naccarati A., Pardini B., Hemminki K., Vodicka P. Sporadic colorectal cancer and individual susceptibility: a review of the association studies investigating the role of DNA repair genetic polymorphisms. Mutat. Res. 2007, 635:118-145.
9. Ricceri F., Matullo G., Vineis P. Is there evidence of involvement of DNA repair polymorphisms in human cancer. Mutat. Res. 2011, August 12 (Epub ahead of print).
10. Vineis P., Manuguerra M., Kavvoura F.K., Guarrera S., Allione A., Rosa F., Di Gregorio A., Polidoro S., Saletta F., Ioannidis J.P., Matullo G. A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility. J. Natl. Cancer Inst. 2009, 101:24-36.
11. Rosenquist T.A., Zharkov D.O., Grollman A.P. Cloning and characterization of a mammalian 8-oxoguanine DNA glycosylase. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:7429-7434.
12. Nishioka K., Ohtsubo T., Oda H., Fujiwara T., Kang D., Sugimachi K., Nakabeppu Y. Expression and differential intracellular localization of two major forms of human 8-oxoguanine DNA glycosylase encoded by alternatively spliced OGG1 mRNAs. Mol. Biol. Cell 1999, 10:1637-1652.
13. Ishida T., Hippo Y., Nakahori Y., Matsushita I., Kodama T., Nishimura S., Aburatani H. Structure and chromosome location of human OGG1. Cytogenet. Cell Genet. 1999, 85:232-236.
14. Bjoras M., Seeberg E., Luna L., Pearl L.H., Barrett T.E. Reciprocal "flipping" underlies substrate recognition and catalytic activation by the human 8-oxo-guanine DNA glycosylase. J. Mol. Biol. 2002, 317:171-177.
15. Bruner S.D., Norman D.P., Verdine G.L. Structural basis for recognition and repair of the endogenous mutagen 8-oxoguanine in DNA. Nature 2000, 403:859-866.
16. Arai K., Morishita K., Shinmura K., Kohno T., Kim S.R., Nohmi T., Taniwaki M., Ohwada S., Yokota J. Cloning of a human homolog of the yeat OGG1 gene that is involved in the repair of oxidative DNA damage. Oncogene 1997, 14:2857-2861.
17. Hill J.W., Hazra T.K., Izumi T., Mitra S. Stimulation of human 8-oxoguanine-DNA glycosylase by AP-endonuclease: potential coordination of the initial steps in base excision repair. Nucleic Acids Res. 2001, 29:430-438.
18. Amouroux R., Campalans A., Epe B., Radicella J.P. Oxidative stress triggers the preferential assembly of base excision repair complexes on open chromatin regions. Nucleic Acids Res. 2010, 38:2878-2890.
19. Hill J.W., Evans M.K. Dimerization and opposite base-dependent catalytic impairment of polymorphic S326C OGG1 glycosylase. Nucleic Acids Res. 2006, 34:1620-1632.
20. Sidorenko V.S., Grollman A.P., Jaruga P., Dizdaroglu M., Zharkov D.O. Substrate specificity and excision kinetics of natural polymorphic variants and phosphomimetic mutants of human 8-oxoguanine-DNA glycosylase. FEBS J. 2009, 276:5149-5162.
21. Bravard A., Vacher M., Moritz E., Vaslin L., Hall J., Epe B., Radicella J.P. Oxidation status of human OGG1-S326C polymorphic variant determines cellular DNA repair capacity. Cancer Res. 2009, 69:3642-3649.
22. Luna L., Rolseth V., Hildrestrand G.A., Otterlei M., Dantzer F., Bjoras M., Seeberg E. Dynamic relocalization of hOGG1 during the cell cycle is disrupted in cells harbouring the hOGG1-Cys326 polymorphic variant. Nucleic Acids Res. 2005, 33:1813-1824.
23. Kiyohara C., Takayama K., Nakanishi Y. Lung cancer risk and genetic polymorphisms in DNA repair pathways: a meta-analysis. J. Nucleic Acids 2010, 2010:701760.
24. Kovtun I.V., Liu Y., Bjoras M., Klungland A., Wilson S.H., McMurray C.T. OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells. Nature 2007, 447:447-452.
25. Coppede F., Migheli F., Ceravolo R., Bregant E., Rocchi A., Petrozzi L., Unti E., Lonigro R., Siciliano G., Migliore L. The hOGG1 Ser326Cys polymorphism and Huntington's disease. Toxicology 2009, 278:199-203.
26. Gangwar R., Ahirwar D., Mandhani A., Mittal R.D. Do DNA repair genes OGG1, XRCC3 and XRCC7 have an impact on susceptibility to bladder cancer in the North Indian population?. Mutat. Res. 2009, 680:56-63.
27. Shinmura K., Kohno T., Kasai H., Koda K., Sugimura H., Yokota J. Infrequent mutations of the hOGG1 gene that is involved in the excision of 8-hydroxyguanine in damaged DNA, in human gastric cancer. Jpn. J. Cancer Res. 1998, 89:825-828.
28. Anderson P.C., Daggett V. The R46Q, R131Q and R154H polymorphs of human DNA glycosylase/beta-lyase hOgg1 severely distort the active site and DNA recognition site but do not cause unfolding. J. Am. Chem. Soc. 2009, 131:9506-9515.
29. Doublie S., Bandaru V., Bond J.P., Wallace S.S. The crystal structure of human endonuclease VIII-like 1 (NEIL1) reveals a zincless finger motif required for glycosylase activity. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:10284-10289.
30. Grin I.R., Dianov G.L., Zharkov D.O. The role of mammalian NEIL1 protein in the repair of 8-oxo-7 8-dihydroadenine in DNA. FEBS Lett. 2010, 584:1553-1557.
31. Dou H., Mitra S., Hazra T.K. Repair of oxidized bases in DNA bubble structures by human DNA glycosylases NEIL1 and NEIL2. J. Biol. Chem. 2003, 278:49679-49684.
32. Dou H., Theriot C.A., Das A., Hegde M.L., Matsumoto Y., Boldogh I., Hazra T.K., Bhakat K.K., Mitra S. Interaction of the human DNA glycosylase NEIL1 with proliferating cell nuclear antigen. The potential for replication-associated repair of oxidized bases in mammalian genomes. J. Biol. Chem. 2008, 283:3130-3140.
33. Wiederhold L., Leppard J.B., Kedar P., Karimi-Busheri F., Rasouli-Nia A., Weinfeld M., Tomkinson A.E., Izumi T., Prasad R., Wilson S.H., Mitra S., Hazra T.K. AP endonuclease-independent DNA base excision repair in human cells. Mol. Cell 2004, 15:209-220.
34. Grin I.R., Khodyreva S.N., Nevinsky G.A., Zharkov D.O. Deoxyribophosphate lyase activity of mammalian endonuclease VIII-like proteins. FEBS Lett. 2006, 580:4916-4922.
35. Jaruga P., Xiao Y., Vartanian V., Lloyd R.S., Dizdaroglu M. Evidence for the involvement of DNA repair enzyme NEIL1 in nucleotide excision repair of (5'R)- and (5'S)-8 5'-cyclo-2'-deoxyadenosines. Biochemistry 2010, 49:1053-1055.
36. Hegde M.L., Hazra T.K., Mitra S. Early steps in the DNA base excision/single-strand interruption repair pathway in mammalian cells. Cell Res. 2008, 18:27-47.
37. Hazra T.K., Das A., Das S., Choudhury S., Kow Y.W., Roy R. Oxidative DNA damage repair in mammalian cells: a new perspective. DNA Repair (Amst.) 2007, 6:470-480.
38. Guan X., Bai H., Shi G., Theriot C.A., Hazra T.K., Mitra S., Lu A.L. The human checkpoint sensor Rad9-Rad1-Hus1 interacts with and stimulates NEIL1 glycosylase. Nucleic Acids Res. 2007, 35:2463-2472.
39. Das A., Boldogh I., Lee J.W., Harrigan J.A., Hegde M.L., Piotrowski J., de Souza Pinto N., Ramos W., Greenberg M.M., Hazra T.K., Mitra S., Bohr V.A. The human Werner syndrome protein stimulates repair of oxidative DNA base damage by the DNA glycosylase NEIL1. J. Biol. Chem. 2007, 282:26591-26602.
40. Forsbring M., Vik E.S., Dalhus B., Karlsen T.H., Bergquist A., Schrumpf E., Bjoras M., Boberg K.M., Alseth I. Catalytically impaired hMYH and NEIL1 mutant proteins identified in patients with primary sclerosing cholangitis and cholangiocarcinoma. Carcinogenesis 2009, 30:1147-1154.
41. Roy L.M., Jaruga P., Wood T.G., McCullough A.K., Dizdaroglu M., Lloyd R.S. Human polymorphic variants of the NEIL1 DNA glycosylase. J. Biol. Chem. 2007, 282:15790-15798.
42. Bandaru V., Sunkara S., Wallace S.S., Bond J.P. A novel human DNA glycosylase that removes oxidative DNA damage and is homologous to Escherichia coli endonuclease VIII. DNA Repair (Amst.) 2002, 1:517-529.
43. Das A., Rajagopalan L., Mathura V.S., Rigby S.J., Mitra S., Hazra T.K. Identification of a zinc finger domain in the human NEIL2 (Nei-like-2) protein. J. Biol. Chem. 2004, 279:47132-47138.
44. Hazra T.K., Kow Y.W., Hatahet Z., Imhoff B., Boldogh I., Mokkapati S.K., Mitra S., Izumi T. Identification and characterization of a novel human DNA glycosylase for repair of cytosine-derived lesions. J. Biol. Chem. 2002, 277:30417-30420.
45. Kinslow C.J., El-Zein R.A., Rondelli C.M., Hill C.E., Wickliffe J.K., Abdel-Rahman S.Z. Regulatory regions responsive to oxidative stress in the promoter of the human DNA glycosylase gene NEIL2. Mutagenesis 2010, 25:171-177.
46. Das A., Wiederhold L., Leppard J.B., Kedar P., Prasad R., Wang H., Boldogh I., Karimi-Busheri F., Weinfeld M., Tomkinson A.E., Wilson S.H., Mitra S., Hazra T.K. NEIL2-initiated, APE-independent repair of oxidized bases in DNA: evidence for a repair complex in human cells. DNA Repair (Amst.) 2006, 5:1439-1448.
47. Das S., Chattopadhyay R., Bhakat K.K., Boldogh I., Kohno K., Prasad R., Wilson S.H., Hazra T.K. Stimulation of NEIL2-mediated oxidized base excision repair via YB-1 interaction during oxidative stress. J. Biol. Chem. 2007, 282:28474-28484.
48. Kinslow C.J., El-Zein R.A., Hill C.E., Wickliffe J.K., Abdel-Rahman S.Z. Single nucleotide polymorphisms 5' upstream the coding region of the NEIL2 gene influence gene transcription levels and alter levels of genetic damage. Genes. Chromosomes Cancer 2008, 47:923-932.
49. Zhai X., Zhao H., Liu Z., Wang L.E., El-Naggar A.K., Sturgis E.M., Wei Q. Functional variants of the NEIL1 and NEIL2 genes and risk and progression of squamous cell carcinoma of the oral cavity and oropharynx. Clin. Cancer Res. 2008, 14:4345-4352.
50. Slupska M.M., Baikalov C., Luther W.M., Chiang J.H., Wei Y.F., Miller J.H. Cloning and sequencing a human homolog (hMYH) of the Escherichia coli mutY gene whose function is required for the repair of oxidative DNA damage. J. Bacteriol. 1996, 178:3885-3892.
51. Ohtsubo T., Nishioka K., Imaiso Y., Iwai S., Shimokawa H., Oda H., Fujiwara T., Nakabeppu Y. Identification of human MutY homolog (hMYH) as a repair enzyme for 2-hydroxyadenine in DNA and detection of multiple forms of hMYH located in nuclei and mitochondria. Nucleic Acids Res. 2000, 28:1355-1364.
52. Fromme J.C., Banerjee A., Huang S.J., Verdine G.L. Structural basis for removal of adenine mispaired with 8-oxoguanine by MutY adenine DNA glycosylase. Nature 2004, 427:652-656.
53. Luncsford P.J., Chang D.Y., Shi G., Bernstein J., Madabushi A., Patterson D.N., Lu A.L., Toth E.A. A structural hinge in eukaryotic MutY homologues mediates catalytic activity and Rad9-Rad1-Hus1 checkpoint complex interactions. J. Mol. Biol. 2010, 403:351-370.
54. Boal A.K., Genereux J.C., Sontz P.A., Gralnick J.A., Newman D.K., Barton J.K. Redox signaling between DNA repair proteins for efficient lesion detection. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:15237-15242.
55. Matsumoto Y. Molecular mechanism of PCNA-dependent base excision repair. Prog. Nucleic Acid Res. Mol. Biol. 2001, 68:129-138.
56. Yang H., Clendenin W.M., Wong D., Demple B., Slupska M.M., Chiang J.H., Miller J.H. Enhanced activity of adenine-DNA glycosylase (Myh) by apurinic/apyrimidinic endonuclease (Ape1) in mammalian base excision repair of an A/GO mismatch. Nucleic Acids Res. 2001, 29:743-752.
57. Parker A.R., Eshleman J.R. Human MutY: gene structure, protein functions and interactions, and role in carcinogenesis. Cell. Mol. Life Sci. 2003, 60:2064-2083.
58. Poulsen M.L., Bisgaard M.L. MUTYH associated polyposis (MAP). Curr. Genomics 2008, 9:420-435.
59. Hayashi H., Tominaga Y., Hirano S., McKenna A.E., Nakabeppu Y., Matsumoto Y. Replication-associated repair of adenine:8-oxoguanine mispairs by MYH. Curr. Biol. 2002, 12:335-339.
60. Gu Y., Parker A., Wilson T.M., Bai H., Chang D.Y., Lu A.L. Human MutY homolog, a DNA glycosylase involved in base excision repair, physically and functionally interacts with mismatch repair proteins human MutS homolog 2/human MutS homolog 6. J. Biol. Chem. 2002, 277:11135-11142.
61. Shi G., Chang D.Y., Cheng C.C., Guan X., Venclovas C., Lu A.L. Physical and functional interactions between MutY glycosylase homologue (MYH) and checkpoint proteins Rad9-Rad1-Hus1. Biochem. J. 2006, 400:53-62.
62. Ali M., Kim H., Cleary S., Cupples C., Gallinger S., Bristow R. Characterization of mutant MUTYH proteins associated with familial colorectal cancer. Gastroenterology 2008, 135:499-507.
63. Shinmura K., Yamaguchi S., Saitoh T., Takeuchi-Sasaki M., Kim S.R., Nohmi T., Yokota J. Adenine excisional repair function of MYH protein on the adenine:8-hydroxyguanine base pair in double-stranded DNA. Nucleic Acids Res. 2000, 28:4912-4918.
64. Miyaishi A., Osawa K., Osawa Y., Inoue N., Yoshida K., Kasahara M., Tsutou A., Tabuchi Y., Sakamoto K., Tsubota N., Takahashi J. MUTYH Gln324His gene polymorphism and genetic susceptibility for lung cancer in a Japanese population. J. Exp. Clin. Cancer Res. 2009, 28:10.
65. Kasahara M., Osawa K., Yoshida K., Miyaishi A., Osawa Y., Inoue N., Tsutou A., Tabuchi Y., Tanaka K., Yamamoto M., Shimada E., Takahashi J. Association of MUTYH Gln324His and APEX1 Asp148Glu with colorectal cancer and smoking in a Japanese population. J. Exp. Clin. Cancer Res. 2008, 27:49.
66. Picelli S., Zajac P., Zhou X.L., Edler D., Lenander C., Dalen J., Hjern F., Lundqvist N., Lindforss U., Pahlman L., Smedh K., Tornqvist A., Holm J., Janson M., Andersson M., Ekelund S., Olsson L., Lundeberg J., Lindblom A. Common variants in human CRC genes as low-risk alleles. Eur. J. Cancer 2010, 46:1041-1048.
67. Theodoratou E., Campbell H., Tenesa A., Houlston R., Webb E., Lubbe S., Broderick P., Gallinger S., Croitoru E.M., Jenkins M.A., Win A.K., Cleary S.P., Koessler T., Pharoah P.D., Kury S., Bezieau S., Buecher B., Ellis N.A., Peterlongo P., Offit K., Aaltonen L.A., Enholm S., Lindblom A., Zhou X.L., Tomlinson I.P., Moreno V., Blanco I., Capella G., Barnetson R., Porteous M.E., Dunlop M.G., Farrington S.M. A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants. Br. J. Cancer 2010, 103:1875-1884.
68. Cheadle J.P., Sampson J.R. MUTYH-associated polyposis - from defect in base excision repair to clinical genetic testing. DNA Repair (Amst.) 2007, 6:274-279.
69. Kundu S., Brinkmeyer M.K., Livingston A.L., David S.S. Adenine removal activity and bacterial complementation with the human MutY homologue (MUTYH) and Y165C, G382D, P391L and Q324R variants associated with colorectal cancer. DNA Repair (Amst.) 2009, 8:1400-1410.
70. D'Agostino V.G., Minoprio A., Torreri P., Marinoni I., Bossa C., Petrucci T.C., Albertini A.M., Ranzani G.N., Bignami M., Mazzei F. Functional analysis of MUTYH mutated proteins associated with familial adenomatous polyposis. DNA Repair (Amst.) 2010, 9:700-707.
71. Goto M., Shinmura K., Nakabeppu Y., Tao H., Yamada H., Tsuneyoshi T., Sugimura H. Adenine DNA glycosylase activity of 14 human MutY homolog (MUTYH) variant proteins found in patients with colorectal polyposis and cancer. Hum. Mutat. 2010, 31:E1861-E1874.
72. Harrison L., Ascione G., Menninger J.C., Ward D.C., Demple B. Human apurinic endonuclease gene (APE): structure and genomic mapping (chromosome 14q11.2-12). Hum. Mol. Genet. 1992, 1:677-680.
73. Izumi T., Henner W.D., Mitra S. Negative regulation of the major human AP-endonuclease, a multifunctional protein. Biochemistry 1996, 35:14679-14683.
74. Akiyama K., Nagao K., Oshida T., Tsutsui K., Yoshida M.C., Seki S. Cloning, sequence analysis, and chromosomal assignment of the mouse Apex gene. Genomics 1995, 26:63-69.
75. Evans A.R., Limp-Foster M., Kelley M.R. Going APE over ref-1. Mutat. Res. 2000, 461:83-108.
76. Izumi T., Brown D.B., Naidu C.V., Bhakat K.K., Macinnes M.A., Saito H., Chen D.J., Mitra S. Two essential but distinct functions of the mammalian abasic endonuclease. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:5739-5743.
77. Xanthoudakis S., Miao G.G., Curran T. The redox and DNA-repair activities of Ref-1 are encoded by nonoverlapping domains. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:23-27.
78. Maher R.L., Bloom L.B. Pre-steady-state kinetic characterization of the AP endonuclease activity of human AP endonuclease 1. J. Biol. Chem. 2007, 282:30577-30585.
79. Kanazhevskaya L.Y., Koval V.V., Zharkov D.O., Strauss P.R., Fedorova O.S. Conformational transitions in human AP endonuclease 1 and its active site mutant during abasic site repair. Biochemistry 2010, 49:6451-6461.
80. Tell G., Quadrifoglio F., Tiribelli C., Kelley M.R. The many functions of APE1/Ref-1: not only a DNA repair enzyme. Antioxid. Redox Signal. 2009, 11:601-620.
81. Bhakat K.K., Mantha A.K., Mitra S. Transcriptional regulatory functions of mammalian AP-endonuclease (APE1/Ref-1), an essential multifunctional protein. Antioxid. Redox Signal. 2009, 11:621-638.
82. Sengupta S., Mantha A.K., Mitra S., Bhakat K.K. Human AP endonuclease (APE1/Ref-1) and its acetylation regulate YB-1-p300 recruitment and RNA polymerase II loading in the drug-induced activation of multidrug resistance gene MDR1. Oncogene 2011, 30:482-493.
83. Tell G., Wilson D.M., Lee C.H. Intrusion of a DNA repair protein in the RNome world: is this the beginning of a new era?. Mol. Cell. Biol. 2010, 30:366-371.
84. Barnes T., Kim W.C., Mantha A.K., Kim S.E., Izumi T., Mitra S., Lee C.H. Identification of apurinic/apyrimidinic endonuclease 1 (APE1) as the endoribonuclease that cleaves c-myc mRNA. Nucleic Acids Res. 2009, 37:3946-3958.
85. Busso C.S., Lake M.W., Izumi T. Post-translational modification of mammalian AP endonuclease (APE1). Cell. Mol. Life Sci. 2010, 67:3609-3620.
86. Chattopadhyay R., Das S., Maiti A.K., Boldogh I., Xie J., Hazra T.K., Kohno K., Mitra S., Bhakat K.K. Regulatory role of human AP-endonuclease (APE1/Ref-1) in YB-1-mediated activation of the multidrug resistance gene MDR1. Mol. Cell. Biol. 2008, 28:7066-7080.
87. Hadi M.Z., Coleman M.A., Fidelis K., Mohrenweiser H.W., Wilson D.M. Functional characterization of Ape1 variants identified in the human population. Nucleic Acids Res. 2000, 28:3871-3879.
88. Ryk C., Routledge M.N., Allan J.M., Wild C.P., Kumar R., Lambert B., Hou S. Influence of DNA repair gene polymorphisms on the initial repair of MMS-induced DNA damage in human lymphocytes as measured by the alkaline comet assay. Environ. Mol. Mutagen. 2008, 49:669-675.
89. Hu J.J., Smith T.R., Miller M.S., Lohman K., Case L.D. Genetic regulation of ionizing radiation sensitivity and breast cancer risk. Environ. Mol. Mutagen. 2002, 39:208-215.
90. Jiao L., Bondy M.L., Hassan M.M., Wolff R.A., Evans D.B., Abbruzzese J.L., Li D. Selected polymorphisms of DNA repair genes and risk of pancreatic cancer. Cancer Detect. Prev. 2006, 30:284-291.
91. Gu D., Wang M., Zhang Z., Chen J. The DNA repair gene APE1 T1349G polymorphism and cancer risk: a meta-analysis of 27 case-control studies. Mutagenesis 2009, 24:507-512.
92. Lu J., Zhang S., Chen D., Wang H., Wu W., Wang X., Lei Y., Wang J., Qian J., Fan W., Hu Z., Jin L., Shen H., Huang W., Wei Q., Lu D. Functional characterization of a promoter polymorphism in APE1/Ref-1 that contributes to reduced lung cancer susceptibility. FASEB J. 2009, 23:3459-3469.
93. Caldecott K.W. Mammalian DNA single-strand break repair: an X-ra(y)ted affair. Bioessays 2001, 23:447-455.
94. Beernink P.T., Hwang M., Ramirez M., Murphy M.B., Doyle S.A., Thelen M.P. Specificity of protein interactions mediated by BRCT domains of the XRCC1 DNA repair protein. J. Biol. Chem. 2005, 280:30206-30213.
95. Nazarkina Z.K., Khodyreva S.N., Marsin S., Lavrik O.I., Radicella J.P. XRCC1 interactions with base excision repair DNA intermediates. DNA Repair (Amst.) 2007, 6:254-264.
96. Mortusewicz O., Leonhardt H. XRCC1 and PCNA are loading platforms with distinct kinetic properties and different capacities to respond to multiple DNA lesions. BMC Mol. Biol. 2007, 8:81.
97. Campalans A., Marsin S., Nakabeppu Y., O'Connor R.T., Boiteux S., Radicella J.P. XRCC1 interactions with multiple DNA glycosylases: a model for its recruitment to base excision repair. DNA Repair (Amst.) 2005, 4:826-835.
98. Vidal A.E., Boiteux S., Hickson I.D., Radicella J.P. XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions. EMBO J. 2001, 20:6530-6539.
99. Whitehouse C.J., Taylor R.M., Thistlethwaite A., Zhang H., Karimi-Busheri F., Lasko D.D., Weinfeld M., Caldecott K.W. XRCC1 stimulates human polynucleotide kinase activity at damaged DNA termini and accelerates DNA single-strand break repair. Cell 2001, 104:107-117.
100. Luo H., Chan D.W., Yang T., Rodriguez M., Chen B.P., Leng M., Mu J.J., Chen D., Songyang Z., Wang Y., Qin J. A new XRCC1-containing complex and its role in cellular survival of methyl methanesulfonate treatment. Mol. Cell. Biol. 2004, 24:8356-8365.
101. Masson M., Niedergang C., Schreiber V., Muller S., Menissier-de Murcia J., de Murcia G. XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol. Cell. Biol. 1998, 18:3563-3571.
102. El-Khamisy S.F., Masutani M., Suzuki H., Caldecott K.W. A requirement for PARP-1 for the assembly or stability of XRCC1 nuclear foci at sites of oxidative DNA damage. Nucleic Acids Res. 2003, 31:5526-5533.
103. Takanami T., Nakamura J., Kubota Y., Horiuchi S. The Arg280His polymorphism in X-ray repair cross-complementing gene 1 impairs DNA repair ability. Mutat. Res. 2005, 582:135-145.
104. Nicoloso M.S., Sun H., Spizzo R., Kim H., Wickramasinghe P., Shimizu M., Wojcik S.E., Ferdin J., Kunej T., Xiao L., Manoukian S., Secreto G., Ravagnani F., Wang X., Radice P., Croce C.M., Davuluri R.V., Calin G.A. Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Res. 2010, 70:2789-2798.
105. Hu Z., Ma H., Chen F., Wei Q., Shen H. XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol. Biomarkers Prev. 2005, 14:1810-1818.
106. Jiang J., Liang X., Zhou X., Huang R., Chu Z., Zhan Q., Lin H. DNA repair gene X-ray repair cross complementing group 1 Arg194Trp polymorphism on the risk of lung cancer: a meta-analysis on 22 studies. J. Thorac. Oncol. 2010, 5:1741-1747.
107. Wang M., Qin C., Zhu J., Yuan L., Fu G., Zhang Z., Yin C. Genetic variants of XRCC1, APE1, and ADPRT genes and risk of bladder cancer. DNA Cell Biol. 2010, 29:303-311.
108. Qu T., Morii E., Oboki K., Lu Y., Morimoto K. Micronuclei in EM9 cells expressing polymorphic forms of human XRCC1. Cancer Lett. 2005, 221:91-95.
109. Vodicka P., Stetina R., Polakova V., Tulupova E., Naccarati A., Vodickova L., Kumar R., Hanova M., Pardini B., Slyskova J., Musak L., De Palma G., Soucek P., Hemminki K. Association of DNA repair polymorphisms with DNA repair functional outcomes in healthy human subjects. Carcinogenesis 2007, 28:657-664.
110. Cornetta T., Festa F., Testa A., Cozzi R. DNA damage repair and genetic polymorphisms: assessment of individual sensitivity and repair capacity. Int. J. Radiat. Oncol. Biol. Phys. 2006, 66:537-545.
111. Li H., Ha T.C., Tai B.C. XRCC1 gene polymorphisms and breast cancer risk in different populations: a meta-analysis. Breast 2009, 18:183-191.
112. Flores-Obando R.E., Gollin S.M., Ragin C.C. Polymorphisms in DNA damage response genes and head and neck cancer risk. Biomarkers 2010, 15:379-399.
113. Tumer T.B., Yilmaz D., Tanrikut C., Sahin G., Ulusoy G., Arinc E. DNA repair XRCC1 Arg399Gln polymorphism alone, and in combination with CYP2E1 polymorphisms significantly contribute to the risk of development of childhood acute lymphoblastic leukemia. Leuk. Res. 2010, 34:1275-1281.
114. Bazo A.P, Salvadori D., Salvadori R.A., Sodre L.P., da Silva G.N., de Camargo E.A., Ribeiro L.R., Salvadori D.M. DNA repair gene polymorphism is associated with the genetic basis of atherosclerotic coronary artery disease. Cardiovasc. Pathol. 2010, 20:e9-e15.
115. Wang B., Wang D., Huang G., Zhang C., Xu D.H., Zhou W. XRCC1 polymorphisms and risk of colorectal cancer: a meta-analysis. Int. J. Colorectal Dis. 2010, 25:313-321.
116. Jiang Z., Li C., Xu Y., Cai S. A meta-analysis on XRCC1 and XRCC3 polymorphisms and colorectal cancer risk. Int. J. Colorectal Dis. 2010, 25:169-180.
117. Hao B., Wang H., Zhou K., Li Y., Chen X., Zhou G., Zhu Y., Miao X., Tan W., Wei Q., Lin D., He F. Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma. Cancer Res. 2004, 64:4378-4384.
118. Hu Z., Ma H., Lu D., Zhou J., Chen Y., Xu L., Zhu J., Huo X., Qian J., Wei Q., Shen H. A promoter polymorphism (-77T>C) of DNA repair gene XRCC1 is associated with risk of lung cancer in relation to tobacco smoking. Pharmacogenet. Genomics 2005, 15:457-463.
119. De Ruyck K., Szaumkessel M., De Rudder I., Dehoorne A., Vral A., Claes K., Velghe A., Van Meerbeeck J., Thierens H. Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk. Mutat. Res. 2007, 631:101-110.
120. Simonelli V., D'Errico M., Palli D., Prasad R., Wilson S.H., Dogliotti E. Characterization of DNA polymerase beta splicing variants in gastric cancer: the most frequent exon 2-deleted isoform is a non-coding RNA. Mutat. Res. 2009, 670:79-87.
121. Thompson T.E., Rogan P.K., Risinger J.I., Taylor J.A. Splice variants but not mutations of DNA polymerase beta are common in bladder cancer. Cancer Res. 2002, 62:3251-3256.
122. Prasad R., Singhal R.K., Srivastava D.K., Molina J.T., Tomkinson A.E., Wilson S.H. Specific interaction of DNA polymerase beta and DNA ligase I in a multiprotein base excision repair complex from bovine testis. J. Biol. Chem. 1996, 271:16000-16007.
123. Singhal R.K., Wilson S.H. Short gap-filling by DNA polymerase β is processive. J. Biol. Chem. 1993, 268:15906-15911.
124. Beard W.A., Shock D.D., Yang X.P., DeLauder S.F., Wilson S.H. Loss of DNA polymerase beta stacking interactions with templating purines, but not pyrimidines, alters catalytic efficiency and fidelity. J. Biol. Chem. 2002, 277:8235-8242.
125. Dogliotti E., Fortini P., Pascucci B., Parlanti E. The mechanism of switching among multiple BER pathways. Prog. Nucleic Acid Res. Mol. Biol. 2001, 68:3-27.
126. Matsumoto Y., Kim K. Excision of deoxyribose phosphate residues by DNA polymerase beta during DNA repair. Science 1995, 269:699-702.
127. Dianova I.I., Sleeth K.M., Allinson S.L., Parsons J.L., Breslin C., Caldecott K.W., Dianov G.L. XRCC1-DNA polymerase beta interaction is required for efficient base excision repair. Nucleic Acids Res. 2004, 32:2550-2555.
128. Kedar P.S., Kim S.J., Robertson A., Hou E., Prasad R., Horton J.K., Wilson S.H. Direct interaction between mammalian DNA polymerase beta and proliferating cell nuclear antigen. J. Biol. Chem. 2002, 277:31115-31123.
129. Prasad R., Dianov G.L., Bohr V.A., Wilson S.H. FEN1 stimulation of DNA polymerase beta mediates an excision step in mammalian long patch base excision repair. J. Biol. Chem. 2000, 275:4460-4466.
130. Guo Z., Zheng L., Dai H., Zhou M., Xu H., Shen B. Human DNA polymerase beta polymorphism, Arg137Gln, impairs its polymerase activity and interaction with PCNA and the cellular base excision repair capacity. Nucleic Acids Res. 2009, 37:3431-3441.
131. Beard W.A, Wilson S.H. Structure and mechanism of DNA polymerase beta. Chem. Rev. 2006, 106:361-382.
132. El-Andaloussi N., Valovka T., Toueille M., Hassa P.O., Gehrig P., Covic M., Hubscher U., Hottiger M.O. Methylation of DNA polymerase beta by protein arginine methyltransferase 1 regulates its binding to proliferating cell nuclear antigen. FASEB J. 2007, 21:26-34.
133. Michiels S., Laplanche A., Boulet T., Dessen P., Guillonneau B., Mejean A., Desgrandchamps F., Lathrop M., Sarasin A., Benhamou S. Genetic polymorphisms in 85 DNA repair genes and bladder cancer risk. Carcinogenesis 2009, 30:763-768.
134. Dantzer F., Nasheuer H.P., Vonesch J.L., de Murcia G., Menissier-de J., Murcia Functional association of poly(ADP-ribose) polymerase with DNA polymerase alpha-primase complex: a link between DNA strand break detection and DNA replication. Nucleic Acids Res. 1998, 26:1891-1898.
135. d'Adda di Fagagna F., Hande M.P., Tong W.M., Lansdorp P.M., Wang Z.Q., Jackson S.P. Functions of poly(ADP-ribose) polymerase in controlling telomere length and chromosomal stability. Nat. Genet. 1999, 23:76-80.
136. + into a nuclear signal. Genes Dev. 2005, 19:1951-1967.
137. Rippmann J.F., Damm K., Schnapp A. Functional characterization of the poly(ADP-ribose) polymerase activity of tankyrase 1, a potential regulator of telomere length. J. Mol. Biol. 2002, 323:217-224.
138. Diefenbach J., Burkle A. Introduction to poly(ADP-ribose) metabolism. Cell. Mol. Life Sci. 2005, 62:721-730.
139. Alkhatib H.M., Chen D.F., Cherney B., Bhatia K., Notario V., Giri C., Stein G., Slattery E., Roeder R.G., Smulson M.E. Cloning and expression of cDNA for human poly(ADP-ribose) polymerase. Proc. Natl. Acad. Sci. U. S. A. 1987, 84:1224-1228.
140. Ame J.C., Spenlehauer C., de G., Murcia The PARP superfamily. Bioessays 2004, 26:882-893.
141. Claybon A., Karia B., Bruce C., Bishop A.J. PARP1 suppresses homologous recombination events in mice in vivo. Nucleic Acids Res. 2010, 38:7538-7545.
142. Lilyestrom W., van der Woerd M.J., Clark N., Luger K. Structural and biophysical studies of human PARP-1 in complex with damaged DNA. J. Mol. Biol. 2010, 395:983-994.
143. Langelier M.F., Ruhl D.D., Planck J.L., Kraus W.L., Pascal J.M. The Zn3 domain of human poly(ADP-ribose) polymerase-1 (PARP-1) functions in both DNA-dependent poly(ADP-ribose) synthesis activity and chromatin compaction. J. Biol. Chem. 2010, 285:18877-18887.
144. Allinson S.L., Dianova I.I., Dianov G.L. Poly(ADP-ribose) polymerase in base excision repair: always engaged, but not essential for DNA damage processing. Acta Biochim. Pol. 2003, 50:169-179.
145. Tao Z., Gao P., Liu H.W. Identification of the ADP-ribosylation sites in the PARP-1 automodification domain: analysis and implications. J. Am. Chem. Soc. 2009, 131:14258-14260.
146. Altmeyer M., Messner S., Hassa P.O., Fey M., Hottiger M.O. Molecular mechanism of poly(ADP-ribosyl)ation by PARP1 and identification of lysine residues as ADP-ribose acceptor sites. Nucleic Acids Res. 2009, 37:3723-3738.
147. Sukhanova M., Khodyreva S., Lavrik O. Poly(ADP-ribose) polymerase 1 regulates activity of DNA polymerase beta in long patch base excision repair. Mutat. Res. 2010, 685:80-89.
148. Woodhouse B.C., Dianova I.I., Parsons J.L., Dianov G.L. Poly(ADP-ribose) polymerase-1 modulates DNA repair capacity and prevents formation of DNA double strand breaks. DNA Repair (Amst.) 2008, 7:932-940.
149. Leppard J.B., Dong Z., Mackey Z.B., Tomkinson A.E. Physical and functional interaction between DNA ligase IIIalpha and poly(ADP-Ribose) polymerase 1 in DNA single-strand break repair. Mol. Cell. Biol. 2003, 23:5919-5927.
150. Figueroa J.D., Malats N., Real F.X., Silverman D., Kogevinas M., Chanock S., Welch R., Dosemeci M., Tardon A., Serra C., Carrato A., Garcia-Closas R., Castano-Vinyals G., Rothman N., Garcia-Closas M. Genetic variation in the base excision repair pathway and bladder cancer risk. Hum. Genet. 2007, 121:233-242.
151. Wang X.G., Wang Z.Q., Tong W.M., Shen Y. PARP1 Val762Ala polymorphism reduces enzymatic activity. Biochem. Biophys. Res. Commun. 2007, 354:122-126.
152. Zhang X., Miao X., Liang G., Hao B., Wang Y., Tan W., Li Y., Guo Y., He F., Wei Q., Lin D. Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer. Cancer Res. 2005, 65:722-726.
153. Lockett K.L., Hall M.C., Xu J., Zheng S.L., Berwick M., Chuang S.C., Clark P.E., Cramer S.D., Lohman K., Hu J.J. The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function. Cancer Res. 2004, 64:6344-6348.
154. Liu H.P., Lin W.Y., Wu B.T., Liu S.H., Wang W.F., Tsai C.H., Lee C.C., Tsai F.J. Evaluation of the poly(ADP-ribose) polymerase-1 gene variants in Alzheimer's disease. J. Clin. Lab. Anal. 2010, 24:182-186.
155. Paz-Elizur T., Elinger D., Leitner-Dagan Y., Blumenstein S., Krupsky M., Berrebi A., Schechtman E., Livneh Z. Development of an enzymatic DNA repair assay for molecular epidemiology studies: distribution of OGG activity in healthy individuals. DNA Repair (Amst.) 2007, 6:45-60.
156. Mazzei F., Guarrera S., Allione A., Simonelli V., Narciso L., Barone F., Minoprio A., Ricceri F., Funaro A., D'Errico M., Vogel U., Matullo G., Dogliotti E. 8-Oxoguanine DNA-glycosylase repair activity and expression: A comparison between cryopreserved isolated lymphocytes and EBV-derived lymphoblastoid cell lines. Mutat. Res. 2010, 718:62-67.
157. Paz-Elizur T., Krupsky M., Elinger D., Schechtman E., Livneh Z. Repair of the oxidative DNA damage 8-oxoguanine as a biomarker for lung cancer risk. Cancer Biomark. 2005, 1:201-205.
158. Decordier I., Loock K.V., Kirsch-Volders M. Phenotyping for DNA repair capacity. Mutat. Res. 2010, 705:107-129.
159. Au W.W., Salama S.A., Sierra-Torres C.H. Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. Environ. Health Perspect. 2003, 111:303-308.
160. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 1988, 175:184-191.
161. Dusinska M., Collins A.R. The comet assay in human biomonitoring: gene-environment interactions. Mutagenesis 2008, 23:191-205.
162. Li C.C., Wang L.E., Wei Q. DNA repair phenotype and cancer susceptibility - a mini review. Int. J. Cancer 2009, 124:999-1007.
163. Kinner A.A., Wu W., Staudt C., Iliakis G. Gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin. Nucleic Acids Res. 2008, 36:5678-5694.
164. Hanova M., Stetina R., Vodickova L., Vaclavikova R., Hlavac P., Smerhovsky Z., Naccarati A., Polakova V., Soucek P., Kuricova M., Manini P., Kumar R., Hemminki K., Vodicka P. Modulation of DNA repair capacity and mRNA expression levels of XRCC1, hOGG1 and XPC genes in styrene-exposed workers. Toxicol. Appl. Pharmacol. 2010, 248:194-200.
165. Kuznetsov S.G, Chang S., Sharan S.K. Functional analysis of human BRCA2 variants using a mouse embryonic stem cell-based assay. Methods Mol. Biol. 2010, 653:259-280.
166. Lee J.E., Choi J.H., Lee J.H., Lee M.G. Gene SNPs and mutations in clinical genetic testing: haplotype-based testing and analysis. Mutat. Res. 2005, 573:195-204.
167. Izarzugaza J.M., Redfern O.C., Orengo C.A., Valencia A. Cancer-associated mutations are preferentially distributed in protein kinase functional sites. Proteins 2009, 77:892-903.
168. Lahiry P., Torkamani A., Schork N.J., Hegele R.A. Kinase mutations in human disease: interpreting genotype-phenotype relationships. Nat. Rev. Genet. 2010, 11:60-74.
169. Torkamani A., Verkhivker G., Schork N.J. Cancer driver mutations in protein kinase genes. Cancer Lett. 2009, 281:117-127.
170. Vasudevan S., Tong Y., Steitz J.A. Switching from repression to activation: microRNAs can up-regulate translation. Science 2007, 318:1931-1934.
171. Landi D., Gemignani F., Naccarati A., Pardini B., Vodicka P., Vodickova L., Novotny J., Forsti A., Hemminki K., Canzian F., Landi S. Polymorphisms within micro-RNA binding sites and risk of sporadic colorectal cancer. Carcinogenesis 2008, 29:579-584.